Last edition
News about "National Cancer Institute "
SMPA and NCI Collaborate to Expand Potential of Enzomenib in Precision Oncology
Enzomenib is an investigational, oral, small-molecule currently being clinically evaluated by SMPA in Phase 1/2 clinical trials for relapsed or refractory acute leukemia.
National Cancer Institute | 15/04/2025 | By Abha
PhotonPharma Receives USD 2.5 Million in Seed Funding Round
This vital funding will support the Phase I clinical trial of Innocell, an innovative therapy for the treatment of advanced ovarian cancer.
National Cancer Institute | 22/08/2024 | By Aishwarya | 294
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy